News

This is the second World TB Day and the end of the first full year since the world encountered COVID-19. We have all worked feverishly to manage this pandemic and its consequences. What impact has ...
Background: The utility of interferon gamma release assays (IGRAs) has been assessed in adults, but remains unclear in children. We reviewed the literature on the use of a commercial IGRA in ...
Interferon Gamma Release Assays (sometimes ELISPOT tests ... pay the chief role in determining whether a latent TB infection becomes active, a test like IGRA, that specifically measures the immune ...
To study the use of interferon-gamma release assay (IFN-γ) (IGRAs) as a diagnostic test for tuberculosis (TB)-associated uveitis (TAU). All subjects underwent investigations to rule out ...
Two types of screening tests for LTBI are available in the U.S. -- the tuberculin skin test (TST) and the interferon-gamma release assay (IGRA). The systematic review showed that pooled estimates ...
Among hospital employees who underwent serial interferon-γ release assay testing ... significance of conversions with low-positive IGRA results has been problematic. Researchers recently ...
The study highlights QIAGEN’s continued leadership in TB infection screening, centered on QuantiFERON-TB Gold Plus test, an interferon-gamma release assay (IGRA). The test is unique to the ...
7 Both tests are known as interferon-γ–release assays (IGRAs) because they measure ... to agree to treatment on the basis of a positive IGRA result as compared with a positive result on a ...
The World Health Organization (WHO) recognises the test as the “only” enzyme-linked immunospot (ELISPOT)-based interferon-gamma release assay (IGRA), notable for its cell number ...
PerkinElmer today announced that its EUROIMMUN business has launched a SARS-CoV-2 Interferon Gamma Release Assay (IGRA) for Research Use Only (RUO) to determine the activity of T-cells reactive to ...
Qiagen currently markets the QuantiFERON-TB Gold Plus test, an interferon-gamma release assay (IGRA) for TB. The new campaign will put a "special focus" on IGRA, the U.S.-European firm said in a ...